Anthem Biosciences Limited

Anthem Biosciences Limited is a Bengaluru-based Contract Research, Development and Manufacturing Organization founded in 2006, offering end-to-end services that span early drug discovery through development and commercial-scale manufacturing. It is among a small set of Indian CRDMOs with integrated capabilities across both New Chemical Entities and New Biological Entities, allowing it to support customers through the entire lifecycle of a molecule under one roof rather than handing projects off between separate specialist vendors. The company has built a distinctive niche in fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides and biosimilar-related compounds, alongside its broader small-molecule and biologics discovery and manufacturing work. It serves more than 150 customers globally, ranging from small and emerging biotech firms to larger established pharmaceutical companies, and employs several hundred scientists and other professionals across its Indian facilities. Ownership is led by promoters Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj. The company has grown revenue and profit steadily over the three years leading up to its listing, aided by its integrated discovery-to-manufacturing model and long-standing relationships with a global, if somewhat concentrated, customer base.

The company allocated about 1.78 crore shares, roughly 30 percent of the total issue, to anchor investors ahead of the IPO opening at the price band ceiling of Rs 570 per share.